Tarbox Family Office’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50
Closed -$2K 492
2022
Q1
$2K Hold
50
﹤0.01% 808
2021
Q4
$2K Hold
50
﹤0.01% 880
2021
Q3
$2K Hold
50
﹤0.01% 925
2021
Q2
$2K Hold
50
﹤0.01% 934
2021
Q1
$2K Hold
50
﹤0.01% 879
2020
Q4
$2K Hold
50
﹤0.01% 829
2020
Q3
$1K Hold
50
﹤0.01% 970
2020
Q2
$1K Hold
50
﹤0.01% 968
2020
Q1
$1K Buy
+50
New +$949 ﹤0.01% 869

Other funds holding HALO

Tarbox Family Office's HALO Position: Q2 2022 in Review

Tarbox Family Office sold out of Halozyme (HALO) in Q2 2022, closing a stake of 50 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in HALO in Q1 2020 and held it in 9 quarters. The position peaked at $2K in Q1 2022. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Tarbox Family Office reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 50 Halozyme shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in Halozyme in Q1 2020 and held it in 9 quarters.
  • Tarbox Family Office's Halozyme position peaked at $2K in Q1 2022.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.